DelNAM's Project Manager Rita Santos will be a speaker 📢 and moderator in the upcoming virtual conference on Bionano Innovation, to be held on June 6th, 2020. Learn more about these sessions and register from anywhere in the world 🌍 via BioNano-20.

LEPABE , INIAV and INSA are collaborating to develop a “Nucleic acid mimic lateral flow assay (NAM-LFA) for the detection of SARS-CoV-2”. This project was approved in the FCT special call RESEARCH 4 COVID-19.

Towards the development of this solution and while assuring everyone’s safety and well-being, we have met last week via videoconference, in order to define next steps and work groups.

The latest Biofilm 🦠 Engineering Lab (BEL) meeting happened last week on the 27th of May, via videoconference 📹. The group learned more about the latest evaluation of LEPABE and shared experiences and doubts regarding the ongoing return to the laboratories 👨‍🔬.

#BEL #LEPABE

The project NAM4Covid19: "Nucleic acid mimic lateral flow assay (NAM-LFA) for the detection of Covid19" was approved in the FCT special call RESEARCH 4 COVID-19.

Coordinated by INIAV, this project counts with the collaboration of our team, led by Delnam's project coordinator, Nuno Azevedo.

The solution proposed in this project will allow a faster detection of SARS-CoV-2 (<1 hour) 🕒, when compared with the WHO recommended protocols that take more than 2 hours. It will also avoid the need for specialized technicians 👨‍🔬 and equipment (needs only a simple heat block), and hence improve SNS' testing capacity to SARS-CoV-2 detection. In collaboration with INSA – National Institute of Health Dr. Ricardo Jorge, national reference laboratory for the SARS-CoV-2 diagnosis, this project proposes to develop a rapid and accurate point-of-care testing (POCT) method for SARS-CoV-2 detection.

#Research #DelNAM #NAM4Covid19